Literature DB >> 29320882

The impact of influenza virus infection in pregnancy.

Lucy K Somerville1, Kerri Basile2, Dominic E Dwyer2,3, Jen Kok2,3.   

Abstract

Data from previous seasonal epidemics and pandemics have confirmed that pregnant women are at increased risk for severe influenza virus infection. Complications including fetal loss, higher rates of hospitalization and maternal death are most notable during the late gestational period. Antiviral therapy and influenza vaccination are recommended in pregnant women as both are effective and safe. This review discusses the epidemiology, pathophysiology, treatment and prevention of influenza virus infection in pregnancy, with a focus on recent developments.

Entities:  

Keywords:  cytokines; influenza; pandemic; pregnancy; vaccine

Mesh:

Substances:

Year:  2018        PMID: 29320882     DOI: 10.2217/fmb-2017-0096

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  21 in total

Review 1.  Clinical Effectiveness and Safety of Antivirals for Influenza in Pregnancy.

Authors:  Eric J Chow; Richard H Beigi; Laura E Riley; Timothy M Uyeki
Journal:  Open Forum Infect Dis       Date:  2021-03-20       Impact factor: 3.835

2.  Views and experiences of maternal healthcare providers regarding influenza vaccine during pregnancy globally: A systematic review and qualitative evidence synthesis.

Authors:  Fatemah Alhendyani; Kate Jolly; Laura L Jones
Journal:  PLoS One       Date:  2022-02-10       Impact factor: 3.240

3.  Morbidity of late-season influenza during pregnancy.

Authors:  Alice J Darling; Jerome J Federspiel; Lauren E Wein; Geeta K Swamy; Sarah K Dotters-Katz
Journal:  Am J Obstet Gynecol MFM       Date:  2021-09-20

4.  Immunoglobulin transmission to infants born to mothers with COVID-19.

Authors:  Mina Shakery Boroujeni; Maryam Azizian; Mahshid Bahrami; Azin Kheradmand; Nooshin Tavoosi; Zeynab Rostamiyan; Khatereh Forouharnejad; Sarina Ahmadian; Iman Naamipouran; Mehdi Kiaei
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-08-15

5.  Measuring Evidence-Based Viral Respiratory Illness Mitigation Behaviors in Pregnant Populations: Development and Validation of a Short, Single-Factor Scale During the COVID-19 Pandemic.

Authors:  Mackenzie D M Whipps; Jennifer E Phipps; Leigh Ann Simmons
Journal:  Disaster Med Public Health Prep       Date:  2022-05-02       Impact factor: 5.556

6.  COVID-19 mRNA vaccines drive differential antibody Fc-functional profiles in pregnant, lactating, and nonpregnant women.

Authors:  Caroline Atyeo; Elizabeth A DeRiso; Christine Davis; Evan A Bordt; Rose M De Guzman; Lydia L Shook; Lael M Yonker; Alessio Fasano; Babatunde Akinwunmi; Douglas A Lauffenburger; Michal A Elovitz; Kathryn J Gray; Andrea G Edlow; Galit Alter
Journal:  Sci Transl Med       Date:  2021-10-27       Impact factor: 19.319

Review 7.  The faces of influenza vaccine recommendation: A Literature review of the determinants and barriers to health providers' recommendation of influenza vaccine in pregnancy.

Authors:  Kathleen F Morales; Lisa Menning; Philipp Lambach
Journal:  Vaccine       Date:  2020-06-02       Impact factor: 3.641

8.  Factors associated with uptake of influenza and pertussis vaccines among pregnant women in South Australia.

Authors:  Hassen Mohammed; Michelle Clarke; Ann Koehler; Maureen Watson; Helen Marshall
Journal:  PLoS One       Date:  2018-06-14       Impact factor: 3.240

9.  Prenatal influenza vaccination rescues impairments of social behavior and lamination in a mouse model of autism.

Authors:  Yingying Wu; Fangfang Qi; Dan Song; Zitian He; Zejie Zuo; Yunjie Yang; Qiongliang Liu; Saisai Hu; Xiao Wang; Xiaona Zheng; Junhua Yang; Qunfang Yuan; Juntao Zou; Kaihua Guo; Zhibin Yao
Journal:  J Neuroinflammation       Date:  2018-08-13       Impact factor: 8.322

10.  Clinical features of pregnant women in Iran who died due to COVID-19.

Authors:  Soheila Amini Moghadam; Parisa Dini; Setare Nassiri; Mahtab Motavaselian; Marzieh Hajibaba; Masoudreza Sohrabi
Journal:  Int J Gynaecol Obstet       Date:  2020-12-02       Impact factor: 4.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.